Skip to main content
Home

Frequently Asked Questions

Common questions about regenerative human biologics, exosome therapy, stem cells, and becoming a provider.

What are human biologics?+

Human biologics are products derived from human tissue, most commonly exosomes, mesenchymal stem cells (MSCs), and Wharton’s Jelly. Licensed healthcare providers use them across regenerative applications such as skin quality, joint support, hair restoration, and wound care. These products are not FDA-approved for these uses and remain an investigational category of medicine.

What is exosome therapy?+

Exosome therapy uses cell-derived extracellular vesicles that carry growth factors, cytokines, and signaling molecules involved in the body’s repair process. Because that repair process underlies most regenerative and wellness services, exosome therapy is often added alongside a provider’s existing offerings rather than as a standalone treatment.

What is the difference between exosomes and stem cells?+

Stem cells are living cells capable of differentiation. Exosomes are acellular vesicles secreted by cells, carrying growth factors and signaling molecules without containing any live cells themselves. Both are used in regenerative medicine, but because exosomes contain no living material, they have simpler storage requirements and can be used in delivery routes, like IV administration, that live cell products aren’t suited for.

How do I become a Sōlix provider?+

Licensed healthcare providers can apply through “Become a Provider” on the Sōlix website. Once approved, your Provider Portal access includes:

  • A business guide for adding regenerative human biologics to your services
  • Wholesale pricing on vetted human biologics
  • Clinical evidence resources
  • Informed consent form templates, including state-specific versions
  • Overnight cryopreserved shipping on every order, direct from the lab to your practice
What are your sourcing standards?+

Every biologic we connect providers to comes from an FDA-registered facility, with documentation from lab to provider so you know exactly what you're receiving:

  • The lab's FDA Establishment Identifier (FEI) number and most recent inspection date
  • A Certificate of Analysis (COA) with every lot
  • Post Thaw Third Party Testing is transparent and available
  • Direct lab verification when needed, including Nano Sight Data reports confirming post-thaw count claims
  • No culture-expanded biologics. Nothing we connect providers to is expanded in culture.
  • Always at wholesale cost for providers
What is Wharton’s Jelly and how is it used?+

Wharton’s Jelly is the gel-like connective tissue found inside the umbilical cord. It naturally contains growth factors, hyaluronic acid, collagens, and other extracellular matrix proteins. Providers may add it to their existing services, including joint, wound, and surgical site applications, based on their own clinical judgment and each patient’s needs. Wharton’s Jelly is not FDA-approved to diagnose, treat, cure, or prevent any disease.

How do exosomes compare to PRP?+

They come from different sources and are prepared differently. PRP (platelet-rich plasma) is made from the patient’s own blood, which is drawn and processed in the office at each visit. The exosomes available through Sōlix are amniotic-derived, acellular extracellular vesicles that are processed in a lab and shipped ready to use, so no blood draw is needed. PRP’s composition depends on the patient’s own blood, so it can vary from person to person and visit to visit. Exosome products are documented by lot with a Certificate of Analysis. Providers may use either one, or both, based on their clinical judgment and each patient’s needs. Exosome therapy is investigational and not FDA-approved to diagnose, treat, cure, or prevent any disease. See our Clinical Evidence page for published research.

What specialties can offer regenerative biologics?+

Licensed providers use regenerative biologics within their scope of practice, adding them to patient care in settings such as med spas and aesthetics, cosmetic surgery, orthopedics, hormone and wellness clinics, and regenerative dentistry. See our Clinical Evidence page for published research from a range of clinical settings.

Do I need additional training to provide human biologics?+

It depends on your license, your state, and how you plan to use them. Sōlix provides business guidance and resources to help you add human biologics to services already within your scope of practice. If you’re considering a new service area, we can point you to the right resources and training so you can add that service safely before adding biologics to it. Always confirm requirements with your state licensing board.

Built by AUSTAN

DISCLAIMER

Sōlix does not own, operate, or manage any laboratory, manufacturing, or compounding facility. All biological products available through this platform are manufactured, processed, and distributed by our independently owned and operated FDA-registered laboratory partners. Sōlix does not distribute, ship, handle, or take possession of any biological product at any point in the supply chain.

Sōlix operates as a provider platform that offers licensed healthcare practitioners access to product ordering, clinical education, implementation support, marketing resources, and business integration tools designed to help practices incorporate regenerative biologics into their clinical offerings.

Sōlix is not a compounding pharmacy or chemical compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Sōlix does not compound, manufacture, repackage, or relabel any drug or biological product.

Sōlix resources are for educational and informational purposes only. Providers are responsible for their own regulatory compliance, licensing, and insurance. Sōlix assumes no liability for how materials are applied in practice.

FDA DISCLAIMER

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products and services referenced on this platform are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Biological products, including but not limited to stem cells, exosomes, Wharton's Jelly, and amniotic tissue allografts, are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271. These products are intended for homologous use only and are administered at the sole discretion of a licensed healthcare provider following individual patient assessment. Results may vary. No guarantees of specific outcomes are made or implied.

All medical decisions, including the use of regenerative biologics, should be made in consultation with a qualified healthcare professional. Sōlix makes no medical claims and assumes no liability for clinical outcomes resulting from the use of products ordered through this platform.

Sōlix provides a provider platform and sales CRM for ordering regenerative human biologics, managing provider relationships, and integrating third-party services including Google Calendar for scheduling and appointment management. For details on how we handle your data, see our Privacy Policy.

Terms & ConditionsPrivacy Policy

We use cookies to improve your experience and analyze site traffic. By continuing, you agree to our use of cookies.

Privacy Policy